Hongyan Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hongyan Wang has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
- Zhongwen Xie
State Key Laboratory of Tea Plant Biology and Utilization, Anhui Agricultural University, Hefei, China
5 shared publications Daxiang Li
State Key Laboratory of Tea Plant Germplasm Innovation and Resource Utilization, School of Food and Nutrition, Joint Research Center for Food Nutrition and Health of IHM
4 shared publicationsMinni Li
State Key Laboratory of Tea Plant Germplasm Innovation and Resource Utilization, School of Food and Nutrition, Joint Research Center for Food Nutrition and Health of IHM, Anhui Agricultural University, Hefei, Anhui 230036, China
4 shared publications- Na Xu
Department of Applied Chemistry School of Materials and Chemistry and State Key Laboratory of Tea Plant Germplasm Innovation and Resource Utilization Anhui Agricultural University Hefei P. R. China
4 shared publications - Daxiang Li
State Key Laboratory of Tea Plant Germplasm Innovation and Resource Utilization, School of Tea Science, Anhui Agricultural University, Hefei 230036, China
3 shared publications Hai Xie
State Key Laboratory of Tea Plant Germplasm Innovation and Resource Utilization, School of Food and Nutrition, Joint Research Center for Food Nutrition and Health of IHM, Anhui Agricultural University, Hefei, Anhui 230036, China
3 shared publications
Latest Publications
- Open Access
- 29 July 2026
- Published by Elsevier in SSRN Electronic Journal
EGCG Combats Obesity by Triggering a BAT-Independent Thermogenic Switch and Remodeling the Immune Microenvironment in Subcutaneous Adipose Tissue
Background: Dysfunctional adipose tissue drives metabolic and immune dysregulation in obesity. Adaptive thermogenesis is a promising therapy, but its efficacy is limited by low brown adipose tissue (BAT) activity. Epigallocatechin gallate (EGCG) has anti-obesity effects, yet it remains unknown whether it can trigger BAT-independent thermogenesis and remodel the adipose immunometabolic environment.Objective: This study investigated whether EGCG counteracts diet-induced obesity by remodeling the immunometabolic microenvironment and activating BAT-independent thermogenesis.Methods: In this study, high-fat diet-induced obese C57BL/6J mice received EGCG intervention via gavage and dietary administration, along with cell experiments. We evaluated the effects of EGCG on metabolic parameters, energy expenditure, adipose browning, macrophage infiltration, oxidative stress, and mitochondrial biogenesis. In addition, correlation analysis, protein–protein interaction (PPI) network analysis, and molecular docking were performed to identify key targets.Results: This study demonstrates that EGCG counteracts diet-induced obesity through a dual mechanism. Firstly, EGCG alleviates adipose tissue inflammation by inhibiting macrophage infiltration and reduces oxidative stress and apoptosis, thereby remodeling the immune microenvironment. More critically, EGCG unlocks a BAT-independent thermogenic pathway. EGCG was found to increase systemic energy expenditure independently of BAT function, and beige adipogenesis in subcutaneous white adipose tissue (scWAT) was also induced in an in vivo model of BAT blockade. Meanwhile, in vitro studies further confirm that EGCG directly stimulates the thermogenic capacity of adipocytes derived from scWAT progenitor cells.Conclusion: This study demonstrates that EGCG ameliorates adipose tissue inflammation and activates a potent BAT-independent thermogenic program in scWAT. This BAT-independent mechanism highlights the multi-target potential of EGCG against metabolic dysfunction.
- 29 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessEGCG Combats Obesity by Triggering a BAT-Independent Thermogenic Switch and Remodeling the Immune Microenvironment in Subcutaneous Adipose Tissue
Background: Dysfunctional adipose tissue drives metabolic and immune dysregulation in obesity. Adaptive thermogenesis is a promising therapy, but its efficacy is limited by low brown adipose tissue (BAT) activity. Epigallocatechin gallate (EGCG) has anti-obesity effects, yet it remains unknown whether it can trigger BAT-independent thermogenesis and remodel the adipose immunometabolic environment.Objective: This study investigated whether EGCG counteracts diet-induced obesity by remodeling the immunometabolic microenvironment and activating BAT-independent thermogenesis.Methods: In this study, high-fat diet-induced obese C57BL/6J mice received EGCG intervention via gavage and dietary administration, along with cell experiments. We evaluated the effects of EGCG on metabolic parameters, energy expenditure, adipose browning, macrophage infiltration, oxidative stress, and mitochondrial biogenesis. In addition, correlation analysis, protein–protein interaction (PPI) network analysis, and molecular docking were performed to identify key targets.Results: This study demonstrates that EGCG counteracts diet-induced obesity through a dual mechanism. Firstly, EGCG alleviates adipose tissue inflammation by inhibiting macrophage infiltration and reduces oxidative stress and apoptosis, thereby remodeling the immune microenvironment. More critically, EGCG unlocks a BAT-independent thermogenic pathway. EGCG was found to increase systemic energy expenditure independently of BAT function, and beige adipogenesis in subcutaneous white adipose tissue (scWAT) was also induced in an in vivo model of BAT blockade. Meanwhile, in vitro studies further confirm that EGCG directly stimulates the thermogenic capacity of adipocytes derived from scWAT progenitor cells.Conclusion: This study demonstrates that EGCG ameliorates adipose tissue inflammation and activates a potent BAT-independent thermogenic program in scWAT. This BAT-independent mechanism highlights the multi-target potential of EGCG against metabolic dysfunction.
- 14 March 2026
- Published by Elsevier in Phytomedicine
- Vol. 155, 158079
Large-leaf yellow tea oligosaccharides alleviate T2DM by promoting GLP-1 secretion and regulating intestinal mucosal barrier
- 14 March 2026
- Published by Elsevier in Phytomedicine
- Vol. 155, 158079
Large-leaf yellow tea oligosaccharides alleviate T2DM by promoting GLP-1 secretion and regulating intestinal mucosal barrier
- 4 November 2025
- Published by Elsevier in Research in Veterinary Science
- Vol. 197, 105948
Unveiling sialylation-related hub genes mediating protective effects of curcumin against intestinal inflammation
- 4 November 2025
- Published by Elsevier in Research in Veterinary Science
- Vol. 197, 105948
Unveiling sialylation-related hub genes mediating protective effects of curcumin against intestinal inflammation
- 19 September 2025
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 73 (39) , 24753-24768
A Novel Acidic Polysaccharide from Eurotium cristatum-Fermented Dark Tea: Structural Characterization and Dual Modulation of Adipose Inflammation-Gut Microbiota Axis
Obesity-associated adipose inflammation and gut dysbiosis exacerbate metabolic dysfunction, yet effective therapies are scarce. This study introduces a novel acidic polysaccharide (FOFTP2) isolated from postfermented dark tea by Eurotium cristatum, focusing on its dual immunomodulatory and prebiotic effects. Structural characterization revealed that FOFTP2 primarily consists of →4)-α-D-GalpA-6-O-Me-(1→ residues, along with rhamnogalacturonan-I/II and arabinogalactan-I/II side chains. Functional analysis demonstrated that FOFTP2 effectively repolarizes pro-inflammatory M1 adipose tissue macrophages to anti-inflammatory M2 phenotypes, reduces adipocyte hypertrophy, and improves systemic dyslipidemia. Additionally, FOFTP2 enriches beneficial gut taxa (Bifidobacterium, Romboutsia) while suppressing inflammation-associated genera (Adlercreutzia, Dubosiella). Multiomics analyses show that FOFTP2 mitigates adipose inflammation and gut dysbiosis, linked to the upregulation of lipid catabolism genes (Acot4, Sphk, Lcn2) and modulation of immune signaling pathways (Itgam, Ccr2, Tlr8). These findings suggest that FOFTP2 acts as a dual-targeting prebiotic immunomodulator, offering a fermented tea-derived strategy to disrupt the gut-adipose inflammatory axis in metabolic disease.
- 19 September 2025
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 73 (39) , 24753-24768
A Novel Acidic Polysaccharide from Eurotium cristatum-Fermented Dark Tea: Structural Characterization and Dual Modulation of Adipose Inflammation-Gut Microbiota Axis
Obesity-associated adipose inflammation and gut dysbiosis exacerbate metabolic dysfunction, yet effective therapies are scarce. This study introduces a novel acidic polysaccharide (FOFTP2) isolated from postfermented dark tea by Eurotium cristatum, focusing on its dual immunomodulatory and prebiotic effects. Structural characterization revealed that FOFTP2 primarily consists of →4)-α-D-GalpA-6-O-Me-(1→ residues, along with rhamnogalacturonan-I/II and arabinogalactan-I/II side chains. Functional analysis demonstrated that FOFTP2 effectively repolarizes pro-inflammatory M1 adipose tissue macrophages to anti-inflammatory M2 phenotypes, reduces adipocyte hypertrophy, and improves systemic dyslipidemia. Additionally, FOFTP2 enriches beneficial gut taxa (Bifidobacterium, Romboutsia) while suppressing inflammation-associated genera (Adlercreutzia, Dubosiella). Multiomics analyses show that FOFTP2 mitigates adipose inflammation and gut dysbiosis, linked to the upregulation of lipid catabolism genes (Acot4, Sphk, Lcn2) and modulation of immune signaling pathways (Itgam, Ccr2, Tlr8). These findings suggest that FOFTP2 acts as a dual-targeting prebiotic immunomodulator, offering a fermented tea-derived strategy to disrupt the gut-adipose inflammatory axis in metabolic disease.
- 19 June 2025
- Published by Springer Nature in Biological Trace Element Research
- Vol. 204 (2) , 820-835
Gene Dynamics in Maternal Nutrition: The Role of Chromium in Mitigating Offspring Obesity
This study investigates the potential mechanisms by which maternal chromium (Cr) supplementation mitigates offspring obesity through identification of key regulatory genes. Sixteen pregnant C57BL/6 mice were randomly allocated to either control (CON) or chromium-supplemented (CR) dietary groups, with nutritional interventions administered throughout gestation and lactation. Post-weaning, all offspring received CR diets until 32 weeks of age. Comparative analysis revealed significant reductions in adipose tissue mass and 136 differentially expressed genes (DEGs) in CR offspring adipose tissue, identified through GEO2R analysis. Functional enrichment analyses revealed significant involvement of these DEGs in critical metabolic pathways: lipid metabolism regulation (PPAR signaling), steroid hormone biosynthesis, cholesterol homeostasis, and fatty acid oxidation processes. Protein-protein interaction network analysis identified 14 hub genes central to adipocyte regulation, including ACSL1, DGAT1, ADIPOQ, PPARD, PPARG, SREBF1, APOC2, and FABP1, which collectively demonstrate synergistic effects in suppressing lipid accumulation. These findings elucidate molecular mechanisms underlying chromium-mediated protection against metabolic disorders and propose novel therapeutic targets for intergenerational obesity prevention. The identified gene network provides a framework for developing maternal nutritional strategies and pharmacological interventions targeting epigenetic regulation of lipid metabolism.
- 19 June 2025
- Published by Springer Nature in Biological Trace Element Research
- Vol. 204 (2) , 820-835
Gene Dynamics in Maternal Nutrition: The Role of Chromium in Mitigating Offspring Obesity
This study investigates the potential mechanisms by which maternal chromium (Cr) supplementation mitigates offspring obesity through identification of key regulatory genes. Sixteen pregnant C57BL/6 mice were randomly allocated to either control (CON) or chromium-supplemented (CR) dietary groups, with nutritional interventions administered throughout gestation and lactation. Post-weaning, all offspring received CR diets until 32 weeks of age. Comparative analysis revealed significant reductions in adipose tissue mass and 136 differentially expressed genes (DEGs) in CR offspring adipose tissue, identified through GEO2R analysis. Functional enrichment analyses revealed significant involvement of these DEGs in critical metabolic pathways: lipid metabolism regulation (PPAR signaling), steroid hormone biosynthesis, cholesterol homeostasis, and fatty acid oxidation processes. Protein-protein interaction network analysis identified 14 hub genes central to adipocyte regulation, including ACSL1, DGAT1, ADIPOQ, PPARD, PPARG, SREBF1, APOC2, and FABP1, which collectively demonstrate synergistic effects in suppressing lipid accumulation. These findings elucidate molecular mechanisms underlying chromium-mediated protection against metabolic disorders and propose novel therapeutic targets for intergenerational obesity prevention. The identified gene network provides a framework for developing maternal nutritional strategies and pharmacological interventions targeting epigenetic regulation of lipid metabolism.
- 2 June 2025
- Published by Wiley in Journal of the Science of Food and Agriculture
- Vol. 105 (11) , 6254-6268
Deciphering a novel polysaccharide from Keemun black tea: structural elucidation and anti‐colorectal cancer exploration
BACKGROUND: Keemun black tea (KBT) is one of the three major black teas in the world, which is famous for unique Keemun aroma and various health‐promoting benefits. However, the structural characteristics and anti‐tumor effects of the principal active polysaccharides in KBT have not been explored.RESULTS: In the present study, a novel homogeneous polysaccharide (KBPW1) with high anti‐tumor activity was isolated from KBT by an activity‐oriented sequential isolation procedure. Structure characterization determined that the molecular weight of KBPW1 was 3.8 × 103 Da, predominantly composed of glucose, arabinose and galactose with a molar ratio of 6.36, 2.62 and 1.02. The backbone of KBPW1 was primarily comprised of →4)‐β‐D‐Glcp‐(1→, β‐D‐Glcp‐(1→, α‐L‐Araf‐(1→, →3,5)‐β‐L‐Araf‐(1→ and →3)‐β‐D‐Galp‐(1→, and its branches were mainly consisted of →4,6)‐β‐D‐Glcp‐(1→, →6)‐β‐D‐Glcp‐(1→ and →5)‐α‐L‐Araf‐(1→). In vitro and in vivo anti‐tumor activity evaluation experiments showed that KBPW1 remarkably induced apoptosis of colorectal cancer cells CT‐26 and effectively inhibited cell proliferation, migration, invasion and colony formation. Moreover, KBPW1 reduced the expression levels of C‐myc, vimentin and Notch1 proteins. Mechanistically, KBPW1 inhibits tumor angiogenesis, metastasis and growth by blocking the Notch signaling and down‐regulating apoptosis‐related proteins expression.CONCLUSION: The findings obtained in the present study suggest that KBPW1 is a potential natural therapeutic agent for colorectal cancer. © 2025 Society of Chemical Industry.
- 2 June 2025
- Published by Wiley in Journal of the Science of Food and Agriculture
- Vol. 105 (11) , 6254-6268
Deciphering a novel polysaccharide from Keemun black tea: structural elucidation and anti‐colorectal cancer exploration
BACKGROUND: Keemun black tea (KBT) is one of the three major black teas in the world, which is famous for unique Keemun aroma and various health‐promoting benefits. However, the structural characteristics and anti‐tumor effects of the principal active polysaccharides in KBT have not been explored.RESULTS: In the present study, a novel homogeneous polysaccharide (KBPW1) with high anti‐tumor activity was isolated from KBT by an activity‐oriented sequential isolation procedure. Structure characterization determined that the molecular weight of KBPW1 was 3.8 × 103 Da, predominantly composed of glucose, arabinose and galactose with a molar ratio of 6.36, 2.62 and 1.02. The backbone of KBPW1 was primarily comprised of →4)‐β‐D‐Glcp‐(1→, β‐D‐Glcp‐(1→, α‐L‐Araf‐(1→, →3,5)‐β‐L‐Araf‐(1→ and →3)‐β‐D‐Galp‐(1→, and its branches were mainly consisted of →4,6)‐β‐D‐Glcp‐(1→, →6)‐β‐D‐Glcp‐(1→ and →5)‐α‐L‐Araf‐(1→). In vitro and in vivo anti‐tumor activity evaluation experiments showed that KBPW1 remarkably induced apoptosis of colorectal cancer cells CT‐26 and effectively inhibited cell proliferation, migration, invasion and colony formation. Moreover, KBPW1 reduced the expression levels of C‐myc, vimentin and Notch1 proteins. Mechanistically, KBPW1 inhibits tumor angiogenesis, metastasis and growth by blocking the Notch signaling and down‐regulating apoptosis‐related proteins expression.CONCLUSION: The findings obtained in the present study suggest that KBPW1 is a potential natural therapeutic agent for colorectal cancer. © 2025 Society of Chemical Industry.
- Open Access
- 17 June 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 137, 112500
Toll-like receptor 4 deficiency affects the balance of osteoclastogenesis and osteoblastogenesis in periodontitis
- 17 June 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 137, 112500
Open AccessToll-like receptor 4 deficiency affects the balance of osteoclastogenesis and osteoblastogenesis in periodontitis
- 18 March 2024
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 72 (13) , 7230-7243
Large Yellow Tea Polysaccharide Alleviates HFD-Induced Intestinal Homeostasis Dysbiosis via Modulating Gut Barrier Integrity, Immune Responses, and the Gut Microbiome
Long-term high-fat diet (HFD) will induce dysbiosis and a disturbance of intestinal homeostasis. Large yellow tea polysaccharide (LYP) has been shown to improve obesity-associated metabolic disease via modulation of the M2 polarization. However, the contribution of LYP to intestinal barrier impairment and improvement mechanisms in obesity caused by an HFD are still not clear. In this study, we evaluated the impacts of LYP on the mucosal barrier function and microbiota composition in HFD-feeding mice. Results exhibited that dietary LYP supplement could ameliorate the physical barrier function via maintaining intestinal mucosal integrity and elevating tight-junction protein production, strengthen the chemical barrier function via up-regulating the levels of glucagon-like peptide-1 and increasing mucin-producing goblet cell numbers, and enhance the intestinal immune barrier function though suppressing immune cell subsets and cytokines toward pro-inflammatory phenotypes. Moreover, LYP reshaped the constitution and metabolism of intestinal flora by enriching probiotics that produce short-chain fatty acids. Overall, LYP might be used as a critical regulator of intestinal homeostasis to improve host health by promoting gut barrier integrity, modulating intestinal immune response, and inhibiting bowel inflammation.
- 18 March 2024
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 72 (13) , 7230-7243
Large Yellow Tea Polysaccharide Alleviates HFD-Induced Intestinal Homeostasis Dysbiosis via Modulating Gut Barrier Integrity, Immune Responses, and the Gut Microbiome
Long-term high-fat diet (HFD) will induce dysbiosis and a disturbance of intestinal homeostasis. Large yellow tea polysaccharide (LYP) has been shown to improve obesity-associated metabolic disease via modulation of the M2 polarization. However, the contribution of LYP to intestinal barrier impairment and improvement mechanisms in obesity caused by an HFD are still not clear. In this study, we evaluated the impacts of LYP on the mucosal barrier function and microbiota composition in HFD-feeding mice. Results exhibited that dietary LYP supplement could ameliorate the physical barrier function via maintaining intestinal mucosal integrity and elevating tight-junction protein production, strengthen the chemical barrier function via up-regulating the levels of glucagon-like peptide-1 and increasing mucin-producing goblet cell numbers, and enhance the intestinal immune barrier function though suppressing immune cell subsets and cytokines toward pro-inflammatory phenotypes. Moreover, LYP reshaped the constitution and metabolism of intestinal flora by enriching probiotics that produce short-chain fatty acids. Overall, LYP might be used as a critical regulator of intestinal homeostasis to improve host health by promoting gut barrier integrity, modulating intestinal immune response, and inhibiting bowel inflammation.